Interazioni tra cellule ossee, cellule tumorali, fattori secreti e PropRietà fisico-chimiche macrO, MIcro e nano- Strutturali del tessuto osseo in prEsenza di METastasi ossee

Title

Code

PROMISE- MET

Type

Sperimentale

Start Year

2022

Status

In Corso

Principal Investigator

051-6366004

francesca.salamanna@ior.it

Salamanna Francesca, Phd

Researcher

Surgical Science and Technologies

Operational unit that carry out the study

complex unit

Scienze e tecnologie chirurgiche

Temporary Director

Giavaresi Gianluca, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. PROMISE-MET

Wednesday 14 December 2022, 15:43

PG0018304_2022_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Interazioni tra cellule ossee, cellule tumorali, fattori secreti e PropRietà fisico-chimiche macrO, MIcro e nano- Strutturali del tessuto osseo in prEsenza di METastasi ossee

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Interazioni tra cellule ossee, cellule tumorali, fattori secreti e PropRietà fisico-chimiche macrO, MIcro e nano- Strutturali del tessuto osseo in prEsenza di METastasi ossee

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in